Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent progress in tolerance induction through mixed chimerism.

Ines Pree1, Nina Pilat, Thomas Wekerle

  • 1Division of Transplantation, Department of Surgery, Vienna General Hospital, Medical University of Vienna, Vienna, Austria.

International Archives of Allergy and Immunology
|June 29, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Donor bone marrow together with recipient regulatory T cells induces chimerism without irradiation in kidney transplantation.

Science translational medicine·2026
Same author

Living Life to the Fullest After Organ Transplantation.

Transplant international : official journal of the European Society for Organ Transplantation·2026
Same author

Donor-reactive clonotypes are overrepresented in the urinary T cell repertoire during kidney transplant rejection and show distinct dynamics in the circulation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

The Top 12 Most Impactful Papers in Clinical Transplantation in 2025: TI Editors' Choice.

Transplant international : official journal of the European Society for Organ Transplantation·2026
Same author

Transplant International: Looking Back at 2025, Looking Forward to 2026.

Transplant international : official journal of the European Society for Organ Transplantation·2026
Same author

Preclinical and clinical developments in Treg therapy for heart transplantation: Critical assessment and translational challenges.

Human immunology·2026
Same journal

Association of Serum Galectin-3 Binding Protein with Acute Exacerbation, Inflammation, and Airway Remodeling in Pediatric Asthma.

International archives of allergy and immunology·2026
Same journal

Effectiveness of a Provincial Law to Improve Epinephrine Use for Anaphylaxis in Schools in Alberta, Canada: A Pre-Post Study.

International archives of allergy and immunology·2026
Same journal

Rab27 a regulates dendritic cell immune tolerogenic capacity.

International archives of allergy and immunology·2026
Same journal

Burden of Hereditary Angioedema in Adults: Impact of Disease and Patient Characteristics.

International archives of allergy and immunology·2026
Same journal

Predictors of Treatment Response to Omalizumab in Children with Chronic Spontaneous Urticaria: A Real World Study.

International archives of allergy and immunology·2026
Same journal

Long-term efficacy beyond 10 years of subcutaneous immunotherapy for house-dust-mite-induced allergic rhinitis: A real-world evidence study.

International archives of allergy and immunology·2026
See all related articles

Inducing mixed hematopoietic chimerism can create donor-specific tolerance in organ transplant recipients. This approach offers a promising alternative to lifelong immunosuppression, though challenges remain for clinical application.

Area of Science:

  • Immunology
  • Transplantation Biology
  • Regenerative Medicine

Background:

  • Organ transplant recipients need lifelong immunosuppression, which has significant side effects and is often ineffective against chronic rejection.
  • Achieving donor-specific tolerance is a critical goal in transplantation to prevent graft loss and improve patient outcomes.
  • Current immunosuppressive therapies are limited by toxicity and failure to prevent long-term graft rejection.

Purpose of the Study:

  • To explore the potential of mixed hematopoietic chimerism for inducing donor-specific tolerance in organ transplantation.
  • To review the progress and challenges in translating mixed chimerism strategies from preclinical models to clinical settings.
  • To highlight mixed hematopoietic chimerism as a novel approach to overcome limitations of current immunosuppression.

Related Experiment Videos

Main Methods:

  • Review of existing literature on mixed hematopoietic chimerism induction and its effects on immune tolerance.
  • Analysis of advancements in bone marrow transplantation protocols, particularly in rodent models.
  • Discussion of the translational challenges in applying these methods to large animal models and human clinical trials.

Main Results:

  • Mixed hematopoietic chimerism can reprogram the immune system to accept donor-specific tissues, establishing a state of tolerance.
  • Successful induction of chimerism has been demonstrated in rodent models using novel bone marrow transplantation protocols.
  • Significant hurdles persist in scaling these protocols for efficacy and safety in larger animal models and human transplantation.

Conclusions:

  • Mixed hematopoietic chimerism presents a promising strategy for achieving permanent donor-specific tolerance, potentially eliminating the need for chronic immunosuppression.
  • Further research and development are required to overcome the translational barriers in bone marrow transplantation for clinical application.
  • The induction of mixed chimerism holds significant potential for revolutionizing organ transplantation by establishing long-term graft acceptance.